Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F. Bray; J. Ferlay; I. Soerjomataram; R. Siegel; Lindsey A. Torre; A. Jemal

DOI:10.3322/caac.21492

Corpus ID: 52188256

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

@article{Bray2018GlobalCS,
  title={Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries},
  author={F. Bray and J. Ferlay and I. Soerjomataram and R. Siegel and Lindsey A. Torre and A. Jemal},
  journal={CA: A Cancer Journal for Clinicians},
  year={2018},
  volume={68}
}

F. Bray, J. Ferlay, +3 authors A. Jemal
Published 2018
Medicine
CA: A Cancer Journal for Clinicians

This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. [...] Key Result In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6…Expand

View on Wiley

acsjournals.onlinelibrary.wiley.com

30,687 Citations

Highly Influential Citations

1,405

Background Citations

13,625

Methods Citations

572

Results Citations

111

Paper Mentions

Observational Patient Registry Clinical Trial

Epidemiological Landscape of Cervical Cancer in Latin America

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of… Expand

Conditions	Uterine Cervical Neoplasms

Latin American Cooperative Oncology Group

July 2021 - June 2028

Interventional Clinical Trial

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

Surgery is the front-line therapy for non-small cell lung cancer (NSCLC) but postoperative complications remains high and patients' long-term outcome is still challenging. In addition… Expand

Conditions	Blood Pressure Management, Dexamethasone, Lung Cancer, (+3 more)
Intervention	Drug, Other

Peking University First Hospital

April 2020 - December 2026

Interventional Clinical Trial

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about 3-5%. Previous retrospective studies showed that perioperative epidural block and/or… Expand

Conditions	Dexamethasone, Epidural Block, Overall Survival, (+2 more)
Intervention	Drug, Other

Peking University First Hospital

September 2019 - July 2026

Interventional Clinical Trial

DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab

Part I (Clinical trial setting): A single-arm phase II study to investigate the efficacy of neoadjuvant atezolizumab (T) + bevacizumab (A) in patients with potentially resectable BCLC… Expand